Health Economics

Review of Outcomes Associated With Formulary Restrictions: Focus on Step Therapy 2010

CIGNA Step Therapy FAQs 2014

Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical Reasons 2017

CARE Congress on Biosimilars 2017

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation 2007

Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation 2017

IfPA: Cost-Motivated Treatment Changes: Implications for Non-Medical Switching 2016

Impact of Therapeutic Switching in Long-Term Care 2008

Impact of non-medical switching on clinical and economic outcomes, resource utilization and medication-taking behavior: a systematic literature review 2016

Position on non-medical switching for diabetes patients 2017

Potential negative consequences of non-consented switch of inhaled medications and devices in asthma patients 2013

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies 2013

Impact of Prior Authorization on the Use and Costs of Lipid- Lowering Medications Among Michigan and Indiana Dual Enrollees in Medicaid and Medicare: Results of a Longitudinal, Population-Based Study 2011

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials 2014

Inappropriate Use of Step Therapy “Fail First” Policies by Health Insurers Can Lead to: Disease Progression, Poor Health Outcomes and Increased Costs 2010

Step Therapy: Legal and Ethical Implications of a Cost-Cutting Measure 2018

Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors 2017

Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation 2012

When medication switching threatens care of children with asthma 2018

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation 2016